TNYA
Closed
Tenaya Therapeutics Inc
1.67
+0.26 (+18.44%)
Last Update: 21 Dec 2024 00:26:00
Yesterday: 1.41
Day's Range: 1.35 - 1.67
Send
sign up or login to leave a comment!
When Written:
3.02
Tenaya Therapeutics Inc is a biotechnology company that is focused on developing treatments for heart disease. The company was founded in 2016 and is based in South San Francisco, California. Tenaya's research is centered around the use of regenerative medicine and gene therapy to treat heart failure and other cardiovascular diseases. The company's lead drug candidate, TTX-080, is a gene therapy designed to restore heart function by increasing the production of a protein called SERCA2a. Tenaya has raised over $130 million in funding from investors such as The Column Group, Casdin Capital, and GV (formerly Google Ventures).
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!